New Delhi Jan 26 PTI The price of Covishield and Covaxin the Covid vaccines which are expected to soon get regular market approval from Indias drug regulator is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150 official sources saidAccording to them the National Pharmaceutical Pricing Authority NPPA has been directed to start working towards capping the price to make the vaccines affordableAs of now Covaxin is priced at Rs 1200 per dose while Covishield costs Rs 780 in private facilities The prices include Rs 150 service charge Both the vaccines are only authorised for emergency use in the countryAn Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation on January 19 recommended granting regular market approval to Covid vaccines Covishield and Covaxin for use in the adult population subject to certain conditionsThe NPPA has been asked to work towards capping the price of the vaccines The price is likely to be capped at Rs 275 per dose along withan additional service charge of Rs 150 an official source saidPrakash Kumar Singh the director government and regulatory affairs at Serum Institue of India had submitted an application to the Drugs Controller General of India on October 25 seeking regular market approval for its Covishiled vaccineA couple of weeks ago V Krishna Mohan the whole-time director at Bharat Biotech submitted complete information on the chemistry manufacturing and controls along with the pre-clinical and clinical data while seeking regular market authorisation for CovaxinCovaxin and Covishield were granted Emergency Use Authorisation EUA on January 3 last year PTI PLB NSD